R. S. Nanra

1.2k total citations
46 papers, 848 citations indexed

About

R. S. Nanra is a scholar working on Pulmonary and Respiratory Medicine, Nephrology and Pharmacology. According to data from OpenAlex, R. S. Nanra has authored 46 papers receiving a total of 848 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 11 papers in Nephrology and 11 papers in Pharmacology. Recurrent topics in R. S. Nanra's work include Drug-Induced Adverse Reactions (7 papers), Renal Transplantation Outcomes and Treatments (5 papers) and Drug-Induced Hepatotoxicity and Protection (5 papers). R. S. Nanra is often cited by papers focused on Drug-Induced Adverse Reactions (7 papers), Renal Transplantation Outcomes and Treatments (5 papers) and Drug-Induced Hepatotoxicity and Protection (5 papers). R. S. Nanra collaborates with scholars based in Australia, United Kingdom and Ireland. R. S. Nanra's co-authors include Priscilla Kincaid‐Smith, Bernard F. Jones, Priscilla Kincaid‐Smith, Steven Kalowski, Paul Trevillian, Alastair Gillies, David Henry, Ian M. Whyte, Christopher Hall and A. D. Hibberd and has published in prestigious journals such as The Lancet, Kidney International and The American Journal of Medicine.

In The Last Decade

R. S. Nanra

45 papers receiving 726 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. S. Nanra Australia 16 269 175 162 143 135 46 848
C. P. Swainson United Kingdom 14 67 0.2× 144 0.8× 65 0.4× 92 0.6× 113 0.8× 43 680
J. Joseph Walshe Ireland 23 226 0.8× 55 0.3× 204 1.3× 319 2.2× 384 2.8× 65 1.3k
William A. Briggs United States 23 118 0.4× 100 0.6× 155 1.0× 272 1.9× 599 4.4× 55 1.6k
William M. Bennett United States 18 182 0.7× 66 0.4× 381 2.4× 166 1.2× 244 1.8× 23 1.6k
Richard S. Muther United States 16 127 0.5× 78 0.4× 72 0.4× 189 1.3× 329 2.4× 32 1.0k
M. Molzahn Germany 13 77 0.3× 51 0.3× 175 1.1× 74 0.5× 155 1.1× 63 666
Chaker Ben Salem Tunisia 13 98 0.4× 88 0.5× 136 0.8× 155 1.1× 158 1.2× 71 839
D P Carlton United States 10 525 2.0× 51 0.3× 272 1.7× 505 3.5× 61 0.5× 17 1.3k
T Talseth Norway 19 77 0.3× 94 0.5× 537 3.3× 101 0.7× 80 0.6× 57 1.4k
Donald A. Feinfeld United States 22 49 0.2× 144 0.8× 200 1.2× 248 1.7× 465 3.4× 63 1.2k

Countries citing papers authored by R. S. Nanra

Since Specialization
Citations

This map shows the geographic impact of R. S. Nanra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. S. Nanra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. S. Nanra more than expected).

Fields of papers citing papers by R. S. Nanra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. S. Nanra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. S. Nanra. The network helps show where R. S. Nanra may publish in the future.

Co-authorship network of co-authors of R. S. Nanra

This figure shows the co-authorship network connecting the top 25 collaborators of R. S. Nanra. A scholar is included among the top collaborators of R. S. Nanra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. S. Nanra. R. S. Nanra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vilayur, Eswari, et al.. (2020). Estimating the glomerular filtration rate in pregnancy: The evaluation of the Nanra and CKD-EPI serum creatinine-based equations. Obstetric Medicine. 14(1). 31–34. 8 indexed citations
2.
Khoshdel, Alireza, Shane Carney, Alastair Gillies, et al.. (2007). Potential roles of erythropoietin in the management of anaemia and other complications diabetes. Diabetes Obesity and Metabolism. 10(1). 1–9. 20 indexed citations
3.
Carney, Shane, Alastair Gillies, Bernard F. Jones, R. S. Nanra, & Paul Trevillian. (2005). Erectile dysfunction in end-stage renal disease: Suffering in silence?. Dialysis & Transplantation. 34(2). 101–104. 1 indexed citations
4.
Khoshdel, Alireza, Shane Carney, Alastair Gillies, et al.. (2005). Haemodialysis‐unresponsive blood pressure: Cardiovascular mortality predictor?. Nephrology. 10(5). 438–441. 14 indexed citations
5.
Henry, David, et al.. (1997). Consumption of non‐steroidal anti‐inflammatory drugs and the development of functional renal impairment in elderly subjects. Results of a case‐control study. British Journal of Clinical Pharmacology. 44(1). 85–90. 68 indexed citations
6.
Heller, Carolin, et al.. (1994). The hypo‐echoic cortical rim in lupus nephritis. Australasian Radiology. 38(1). 46–47. 2 indexed citations
7.
Wang, Hongwei, et al.. (1994). Eosinophils in acute renal allograft rejection. Transplant Immunology. 2(1). 41–46. 29 indexed citations
8.
Gani, Jon, et al.. (1991). Use of the Fistula Assessment Monitor to Detect Stenoses in Access Fistulae. American Journal of Kidney Diseases. 17(3). 303–306. 20 indexed citations
9.
Hibberd, A. D., et al.. (1991). Reversal of acute glomerular renal allograft rejection: a possible effect of OKT3. Transplant International. 4(4). 246–248. 3 indexed citations
10.
BRINSMEAD, M. W., et al.. (1990). Urinary corticotropin-releasing hormone immunoreactivity is elevated during human pregnancy. Gynecological Endocrinology. 4(4). 233–244. 5 indexed citations
11.
Jones, Bernard F., Paul Trevillian, & R. S. Nanra. (1984). Serum Sickness due to Rh(anti‐D) Immunoglobulin. Australian and New Zealand Journal of Obstetrics and Gynaecology. 24(1). 49–50. 2 indexed citations
12.
Nanra, R. S.. (1983). Renal effects of antipyretic analgesics. The American Journal of Medicine. 75(5). 70–81. 31 indexed citations
13.
Egger, Garry, et al.. (1981). Consequences of Legislative Restriction on the Sale of Compound Analgesics in Newcastle (N.S.W., Australia). Australian and New Zealand Journal of Medicine. 11(5). 654–657. 7 indexed citations
14.
Jones, Bernard F. & R. S. Nanra. (1979). DOUBLE-BLIND TRIAL OF ANTIHYPERTENSIVE EFFECT OF CHLOROTHIAZIDE IN SEVERE RENAL FAILURE. The Lancet. 314(8155). 1258–1260. 34 indexed citations
15.
Mathew, Timothy H., David H. Clyne, R. S. Nanra, et al.. (1974). A CONTROLLED TRIAL OF ORAL ANTICOAGULANTS AND DIPYRIDAMOLE IN CADAVERIC RENAL ALLOGRAFTS. The Lancet. 303(7870). 1307–1310. 28 indexed citations
16.
Kalowski, Steven, et al.. (1973). DETERIORATION IN RENAL FUNCTION IN ASSOCIATION WITH CO-TRIMOXAZOLE THERAPY. The Lancet. 301(7800). 394–397. 79 indexed citations
17.
Nanra, R. S. & Priscilla Kincaid‐Smith. (1971). Salicylates and papillary necrosis.. BMJ. 2(5752). 45.1–45. 4 indexed citations
18.
Nanra, R. S. & Priscilla Kincaid‐Smith. (1970). Papillary Necrosis in Rats Caused by Aspirin and Aspirin-containing Mixtures. BMJ. 3(5722). 559–561. 90 indexed citations
19.
Nanra, R. S., et al.. (1969). The use of the modified PSP excretion test in the clinical management of patients with renal allografts.. PubMed. 1(21). 1083–7. 2 indexed citations
20.
Nanra, R. S.. (1962). ANALGESIC NEPHROPATHY*. The Medical Journal of Australia. 1(20). 745–748. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026